August 17, 2009 - Elekta has received a multiple order of six radiation therapy systems from the Cancer Institute of the State of São Paulo. The order encompasses two Elekta Synergy Platform, three Elekta Synergy and one Elekta Axesse. Elekta will make the institute its training and product development center in Latin America.

The Cancer Institute of the State of São Paulo, ICESP, is a social organization of Health, created by the State Government in partnership with the Foundation School of Medicine to be the largest hospital specializing in the treatment of cancer in Latin America.

By winning this public tender, Elekta will make the institute its training and product development center in Latin America with the entire product portfolio available including hardware, software, planning system, management system and linear accelerators. The institute will be equipped with two Elekta Synergy Platform, three Elekta Synergy, one Elekta Axesse, 30 MOSAIQ stations and 19 CMS treatment planning systems.

About 6,000 patients diagnosed with cancer are treated at the institute every month, and attended by some of Brazil's most qualified professionals in this specialty. A key feature of the institute is the innovation in assistance, which allows the patient to have all phases of his care, diagnosis and rehabilitation, integrated in the same place.

Besides medical care, the professionals of ICESP develop teaching and research activities in accordance with the medical model of education introduced by the University of São Paulo Medicine - USP. The goal is to transform the institute into a research center of international reference in the area of cancer, including the study of new drugs and innovative treatments for the disease.

Elekta started its own subsidiary in São Paulo in the beginning of 2008, an investment, which has been a success. The Latin American market has successfully proved to be a growth market for Elekta.

Elekta Synergy Platform is a unique linear accelerator that is X-ray volume imaging (XVI) - ready. Based on the IMRT technology developed by Elekta, modifications have been undertaken in order to maintain isocenter accuracy and stability while incorporating the facility to add the additional weight of imaging, detector and robotic technology into the drum design of the treatment machine at a later stage.

Elekta Synergy, the first advanced multi-functional linear accelerator with intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT), enables clinicians to both image and treat patients in the same frame of reference, at the time of treatment. The result is unmatched clinical confidence, enabling more aggressive treatment of tumors while minimizing damage to surrounding healthy tissue.

Elekta Axesse is a fully integrated stereotactic system that combines true three-dimensional (3D) image guidance at the time of treatment with highly conformal beam shaping and robotic 6D sub-millimeter patient positioning to deliver fast, efficient and accurate treatment.

MOSAIQ is an image-enabled oncology electronic medical record (EMR) with fully integrated business features such as scheduling, billing and management reporting and analysis.

For more information: www.elekta.com

Related Content

News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
Feature | Radiation Therapy

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Radiation Therapy

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
News | Lung Imaging

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

Time September 23, 2021
arrow
News | Radiation Oncology

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
News | Radiation Oncology

September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means ...

Time September 20, 2021
arrow
Subscribe Now